• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description may have changed. Be sure to look at the supplements to get an up-to-date view of this device.
 
DeviceREBEL PLATINUM CHROMIUM CORONARY STENT SYSTEM MONORAIL AND OVER THE WIRE
Classification Namestent, coronary
Generic Namestent, coronary
Applicant
Boston Scientific Corp.
one scimed place
maple grove, MN 55311-1566
PMA NumberP130030
Date Received12/30/2013
Decision Date06/27/2014
Product Code
MAF[ Registered Establishments with MAF ]
Docket Number 14M-1060
Notice Date 07/23/2014
Advisory Committee Cardiovascular
Clinical Trials NCT01419171
NCT01703000
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for the rebel platinum chromium coronary stent system (monorail and over-the-wire). This device is indicated for improving coronary luminal diameter in patients with de novo lesions <= 28 mm in length in native coronary arteries with a reference vessel diameter (rvd) of >= 2. 25 to >= 4. 50 mm.
Approval Order Approval Order
Summary Summary of Safety and Effectiveness
Labeling Labeling
Labeling Part 2
Supplements: S001 S002 S003 S004 S005 S006 S007 S008 S009 
S010 S011 S012 S014 S015 S016 S017 S018 S019 
S020 S021 S022 S024 
-
-